Masimo Q1 rev $492.8M (healthcare $339.6M), GAAP EPS $0.35, Non-GAAP $0.77; lifts FY2024 outlook

MASIMO CORP

2024-Q1 EPS reported $0.35 revenue$492,800,000

Consolidated Q1 revenue $492.8M; healthcare $339.6M, non-healthcare $153.2M.
GAAP net income $18.9M ($0.35 diluted EPS); non-GAAP net income $41.9M ($0.77 diluted EPS).
Sensor manufacturing shift from Mexico to Malaysia improved healthcare gross margins ahead of schedule.
Raises FY2024 healthcare revenue guidance to $1.355-1.385B and non-GAAP EPS to $3.54-3.70.
Pursuing separation of consumer business; management finalizing structure for board review.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

MASIMO CORP reported first quarter ended March 30, 2024 results: revenue $492.8 million, net income $18.9 million, EPS $0.35 per diluted share. Guidance raised.

Period: first quarter ended March 30, 2024
Revenue: $492.8 million
Net income: $18.9 million
EPS: $0.35 per diluted share
Guidance: raised
Result: reported results

Exact text from the filing

by specific reference in such filing. --- EX-99.1 (EX-99.1) --- Masimo Reports First Quarter 2024 Financial Results First Quarter 2024 Highlights: • Consolidated revenue was $492.8 million; • Healthcare revenue was $339.6 million; • Non-healthcare revenue was $153.2 million; • GAAP net income per diluted share was $0.35; and • Non-GAAP net income per diluted share

View on SEC.gov

708 earnings releases filed in the last 30 days. Browse all earnings releases →

MASIMO CORP filing history →

Source: SEC EDGAR

accession 0000937556-24-000040

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.